This is a multi-part message in MIME format.

--part0_881619373_boundary
Content-ID: <[log in to unmask]>
Content-type: text/plain; charset=US-ASCII



--part0_881619373_boundary
Content-ID: <[log in to unmask]>
Content-type: text/plain;
        name="PARKINSN.txt#1"
Content-transfer-encoding: quoted-printable
Content-disposition: inline

There are 19 messages totalling 1047 lines in this issue.

Topics in this special issue:

  1. Udall next steps; PWP Congress; Unity
  2. Health for profit...
  3. NEWS: Getting Vitamin C on the Brain
  4. better than collagen
  5. I've learned... (2)
  6. Gamma Knife May Replace Surgery For Parkinson's Patients
  7. R: New member (2)
  8. HEADS UP =3D OTC Drugs & PD
  9. Requip Diary Days 8 thru 12 by Dale Severance (3)
 10. dear
 11. BERNIE BARBER'S WP FILE CONVERTED TO TXT <fwd>
 12. Another Survey? Brian Collins et al
 13. FW: Elizabeth Butler
 14. PMID: 9371905: Olfactory dysfunction in familial PD 27/0 USA -Reply
 15. CSRINDX DEC 97 Part 2 of 2

----------------------------------------------------------------------

Date:    Thu, 4 Dec 1997 01:13:06 +0000
From:    Phil Tompkins <[log in to unmask]>
Subject: Udall next steps; PWP Congress; Unity

This has been my first year of involvement with the Udall Bill.
Because my crazy job limits my personal time and energy, and because
I have no experience in political activism, I've remained a PFC in
the activist chain of command.  My remarks here are those of a
newcomer, so please tell me if I'm way off base.

I'm guessing that attention is being given to unity and a PWP
Congress at this point in the Udall Bill's life-cycle because of
friction encountered among the PD organizations while working for the
bill's passage. The friction is unfortunate, because, I would think,
Udall Bill implementation at a detailed level, along with efforts to
ensure appropriations, ought to be the focus right now. Is there too
much dissention now for this to occur?

It appears that we have little time.  As I understand it, although
the Udall Bill "authorizes" $100 million for fiscal year 1998, plus
unspecified amounts for fiscal 1999 and 2000, all the NIH
appropriations for 1998 (which include an increase but do not include
the $100 million, because the latter was just authorized) have
already been made (in the Labor, Health and Human Services general
approprations bill which Congress just passed this November -- the
bill to which the Udall authorization was attached as an amendment).
I'm just beginning to learn about the federal budget process, and
it's my impression (correct me if I'm wrong) that authorized
programs generally receive appropriations after being included in
the President's budget.  The President presents the 1999 budget to
Congress in January 1998.

It appears we missed getting the $100 million appropriated for 1998,
since it was just recently authorized.  But unless the authorized
Udall measures are covered in the 1999 budget, won't we miss out on
1999 appropriations as well?

It would seem to me that you have a chance of getting a program into
the budget if it has a detailed blueprint along with support of the
President.  I am aware that PAN is addressing the matter of 1999
appropriations, and that at some point we grassroots people will be
requested to do something.  Are NPF, APDA, et. al. addressing this
as well?

Of course there are ongoing strategic issues which it is appropriate
for a PWP Congress to address.  But do our activists have sufficient
time and energy for this now, when effort is needed to work for the
appropriations?

Phil Tompkins
Hoboken NJ
59/8

------------------------------

Date:    Thu, 4 Dec 1997 00:14:56 -0500
From:    KEn Becker <[log in to unmask]>
Subject: Re: Health for profit...

Judith, it is nice to know there is resistance to the "show me the money"
attitude.
Patients and their families should start asking questions before choosing
insurance and medical facilities.  When you are suffering and need quick
treatment, there is usually no time to change things.  Many employers giv=
e a
choice between plans that let you use a doctor of your choice, and those =
that
force you to use a doctor associated with the plan, and many require you =
to
see a that doctor before you get to see a specialist. I pay plenty for th=
e
right to choose any doctor, and I can save money by going to one on the
official list, but I feel that my health is too important to trust to
strangers!   I'd rather use a doctor reccommended by a happy patient, tha=
n
one picked by the insurance company because he is willing to work "cheap"=
  or
would avoid reccommending proper treatments due to the cost factor.  You
wouldn't take a Jaguar to a Yugo dealer for service to save a few bucks, =
 so
why risk your life and well being for money?? Ken B

------------------------------

Date:    Thu, 4 Dec 1997 00:29:13 EST
From:    Elf 808 <[log in to unmask]>
Subject: Re: NEWS: Getting Vitamin C on the Brain

Ron,
 If it's possiable would you mind sending more detailed info on "lipoic a=
cid"
....or directing me to a website that has real information about this sub=
stance
<can ya tell I don't wanna (unless I have to) scroll thru "try me, buy me=
"
ads> ... Thanks ... Elf in TN...Romona
 http://members.aol.com/elf808/index.html   <---newbie webpage but it's i=
n
color <G>
Elf wife to Tony (my hero), and mom to Tori (age 9, nda), Zach (age 7,
multichallenged), Cory (age5, multichallenged). The boys have no definati=
ve Dx
but several labels... Ataxia,Nystagmus, Strubismus, Dystonia, Parkinsonis=
m,
Asthma, Execma, Hypotonia, Spasticity....ect  Collectively the
Dystonia/Parkinsonism effects the boys from eyes to toes and progressing
steadily. Currently Cory & Zach are taking Sinemet, Lodosyn and Cory has =
had 4
rounds of Botox, uses a walker or WC for mobility.
In a message dated 97-12-03 15:54:18 EST, you write:

<<
 Why is everyone so concerned about getting Vit E and C to the brain.  If=
 you
 think that antioxidants will help, just take lipoic acid.  It not only
 reaches the brain, it has been shown to reach the substantia nigra.  It =
is a
 very powerful antioxidant and it recycles E which recycles C.

 Plus it generates L-glutatione which is scarce in PD people.  It also
 chelates Iron.

 Builds strong brains in 4 ways!

                         Ron Reiner (49/2) >>

------------------------------

Date:    Wed, 3 Dec 1997 21:35:33 -0800
From:    David Moreland <[log in to unmask]>
Subject: better than collagen

A few months ago I was very interested in a possible collagen injection f=
or
a temporary repair job for my vocal chords. Since then I have had speech
therapy. What my speech therapist did was have me do some neck exercises.
The result has been that my vocal chords have been built up naturally and=
 I
can continue with the exercises and my volume  will continue to improve. =
I
have begun to sing more and now I am using Dragon Dictate both at home an=
d
at work. This will encourage me to enunciate more precicely. This should
help and my speech should continue to improve. This is just my experience
and I am excited about the way it is working so far. This takes some work
but I think it is worth while.


Yours and His

David L. Moreland, 54/10
[log in to unmask]

------------------------------

Date:    Thu, 4 Dec 1997 00:44:40 -0500
From:    KEn Becker <[log in to unmask]>
Subject: Re: I've learned...

Art, thanks for sharing that, it's like reading a month's worth of Ann
Landers columns in five minutes! Ken B

------------------------------

Date:    Thu, 4 Dec 1997 01:34:36 -0500
From:    Judith Richards <[log in to unmask]>
Subject: Gamma Knife May Replace Surgery For Parkinson's Patients

RSNA MEETING: Noninvasive Gamma Knife May Replace Surgery For Many Patien=
ts
With Parkinson's

CHICAGO, IL -- December 3, 1997 -- A noninvasive radiosurgical technique =
may
ultimately replace surgery for many patients with Parkinson's disease and
other movement disorders whose symptoms cannot be controlled by medicine,
according to results of a preliminary study presented today during the 83=
rd
Scientific Assembly and Annual Meeting of the Radiological Society of Nor=
th
America (RSNA).

"Stereotactic radiosurgery shows promise as an alternative to surgery to
relieve the uncontrolled movements that are characteristic of Parkinson's
disease and other movement disorders," said David Friedman, M.D. of
Philadelphia's Thomas Jefferson University Hospital.

The technique is performed with equipment called a gamma knife that uses
magnetic resonance (MR) imaging to identify the radiosurgical target. The
radiation destroys selected portions of the globus pallidus or the thalam=
us,
structures deep within the brain that are responsible for the tremors and
other involuntary movements that are characteristic of Parkinson's diseas=
e.

The surgical treatment for Parkinson's disease is to make a small hole in
the skull and place a probe into the brain which heats and destroys the
targeted tissue, according to Howard W. Goldman, M.D., Ph.D., professor a=
nd
vice chair, department of neurosurgery.

"Our study looked at the success with the gamma knife in patients who wer=
e
too old or ill to undergo surgery," Dr. Goldman said. "We've had such
success, we're now offering it as an alternative to other patients as wel=
l."

According to Dr. Goldman, as many as 50,000 patients in the United States
could benefit from the technique each year. "Nearly everyone with
Parkinson's disease eventually becomes refractory to pharmaceutical
treatment or develops side effects to medication, usually after five to
eight years of treatment," he said.

In the study reported by Dr. Friedman, 12 patients were treated with the
gamma knife. Seven patients showed marked improvement in their symptoms,
three had moderate improvement and two showed mild improvement with
follow-up of three months.

"With radiosurgery, it takes approximately six to eight weeks to begin to
see the effect of the treatment, according to Dr. Friedman. The results a=
t
three months were comparable to those achieved with surgery, he said.

Thalamotomy -- destruction of tissue in the thalamus -- is used to contro=
l
tremors. Pallidotomy -- destruction of tissue in the globus pallidus -- i=
s
used to control rigidity and larger involuntary movements, Dr. Friedman s=
aid.

The advantages of radiosurgical thalamotomy or pallidotomy with the gamma
knife compared to conventional surgery, according to Dr. Friedman and Dr.
Goldman are:

-- It is a noninvasive procedure without the risks of hemorrhage or
infection that are associated with open surgery. "The only adverse effect
seen with the gamma knife was late-onset swelling of brain tissue in two
patients that largely resolved over time," Dr. Friedman said. Swelling al=
so
can be a side effect of conventional surgery, Dr. Goldman said.

-- Patients are hospitalized for only 24 hours compared to three or more
days with surgery.

-- There is little or no recovery time. Recovery from surgery takes about
two weeks. "The effects of the gamma knife occur gradually, so we typical=
ly
don't see side effects such as weakness and confusion that sometimes occu=
r
immediately after surgery," Dr. Goldman said.

There are 90 gamma knife machines in use worldwide, 32 in the United Stat=
es.

------------------------------

Date:    Thu, 4 Dec 1997 09:37:12 +0100
From:    Piergiorgio Rena <[log in to unmask]>
Subject: R: New member

Dear Leonard

Thank You for Your welcome. Keep in touch and have a nice time.
Piergiorgio

> ----------
> Da:           Fleurette Leonard[SMTP:[log in to unmask]]
> Inviato:      venerd=EC 28 novembre 1997 16.59
> A:            Multiple recipients of list PARKINSN
> Oggetto:      Re: New member
>
> Peirgiorgio - Welcome to the List, and here's hoping we can help.
> Italy!
> Wow we are becoming truly international!  Kind of you to want to help
> your
> father - keep in touch.  Flo
>
>
>
> At 11:09 AM 11/28/97 +0100, you wrote:
> >Dear members
> >
> >Thank You for the welcome. My name is Piergiorgio Rena and I live in
> >Rivoli (close to Torino, Italy). I am 34 years old and I work at Fiat
> >Research Center: i deal with electric traction.
> >My father has been suffering from Parkinson disease since 1982 and he
> is
> >62 years old. Every Saturday morning we attend the meetings of the
> >support group  organised by the local section of the AIP (Parkinson
> >Italian Association). The main purpose of this meeting is to provide,
> in
> >addition to the medication update, a psycological support to the
> >patients, in order to increase their self-confidence, their
> creativity:
> >in practice, to improve the quality of their lives.
> >I would like to know if there are other members involved in this type
> of
> >activities and which are their initiatives at the purpose.
> >I do not have a personal computer at home: I have to use my office PC
> so
> >I do not have so much time to write and to read the messages I get:
> in
> >any case I will do my best to make it!
> >Tomorrow mornig I will be busy as a receptionist at the annual
> meeting
> >organised in Torino by the Parkinson Italian Association.
> >My  E-Mail adress is: [log in to unmask]
> >
> >Best regards to everyone
> >Piergiorgio Rena
> >
>

------------------------------

Date:    Thu, 4 Dec 1997 09:42:14 +0100
From:    Piergiorgio Rena <[log in to unmask]>
Subject: R: New member

Dear Leonard

Thank You for Your welcome.

> ----------
> Da:           Fleurette Leonard[SMTP:[log in to unmask]]
> Inviato:      venerd=EC 28 novembre 1997 16.59
> A:            Multiple recipients of list PARKINSN
> Oggetto:      Re: New member
>
> Peirgiorgio - Welcome to the List, and here's hoping we can help.
> Italy!
> Wow we are becoming truly international!  Kind of you to want to help
> your
> father - keep in touch.  Flo
>
>
>
> At 11:09 AM 11/28/97 +0100, you wrote:
> >Dear members
> >
> >Thank You for the welcome. My name is Piergiorgio Rena and I live in
> >Rivoli (close to Torino, Italy). I am 34 years old and I work at Fiat
> >Research Center: i deal with electric traction.
> >My father has been suffering from Parkinson disease since 1982 and he
> is
> >62 years old. Every Saturday morning we attend the meetings of the
> >support group  organised by the local section of the AIP (Parkinson
> >Italian Association). The main purpose of this meeting is to provide,
> in
> >addition to the medication update, a psycological support to the
> >patients, in order to increase their self-confidence, their
> creativity:
> >in practice, to improve the quality of their lives.
> >I would like to know if there are other members involved in this type
> of
> >activities and which are their initiatives at the purpose.
> >I do not have a personal computer at home: I have to use my office PC
> so
> >I do not have so much time to write and to read the messages I get:
> in
> >any case I will do my best to make it!
> >Tomorrow mornig I will be busy as a receptionist at the annual
> meeting
> >organised in Torino by the Parkinson Italian Association.
> >My  E-Mail adress is: [log in to unmask]
> >
> >Best regards to everyone
> >Piergiorgio Rena
> >
>

------------------------------

Date:    Thu, 4 Dec 1997 03:55:52 EST
From:    DeitzM <[log in to unmask]>
Subject: Re: HEADS UP =3D OTC Drugs & PD

BArb Mallut wrote

It's been so long since I've had a cold that I have no memories of ever t=
aking
Sudafed, but it's none-the-less one of those "household words," like aspi=
rin,
Tylenol, Alka Seltzer and other popular over-the-counter medications, and=
 I
suspect I'd had it 'round the house in the past, if not for myself, then =
when
my kids were growing up.

Because it was such a familiar drug, I never even so much as glanced at t=
he
"Warning" on the  Sudafed box when I took the drug.  Later on, I picked u=
p the
box to see how often the drug can be taken and THEN I casually read the
"Warning" on it.  It said:

"Do not use this product is you are taking a prescription monoamine oxida=
se
inhibitor (MAO) (certain drugs for depression, psychiatric or emotional
conditions, or Parkinson's disease), or for 2 weeks after stopping the MA=
O
drug."

Barb

As an RN (non practicing but retain license in CA) I suggest that when ta=
king
OTC meds that you read the labels and precautions three times before
purchasing.

Helen

------------------------------

Date:    Thu, 4 Dec 1997 04:27:05 -0500
From:    digest  Dale Severance <[log in to unmask]>
Subject: Requip Diary Days 8 thru 12 by Dale Severance

12/3/97  Day 8th thru 12th on requip

I have been so bad I could not keep up the diary. I have been frozen to t=
he
point I could barely initiate any action.
During this period I titrated up to 1 mg 3x a day and today starts 1mg 3x=
 a
day
I've slept most of the time the last 3-4 days letting the tiredness and
fatigue take its course. My  freezing has effected my upper body more tha=
n
lower part but both effected.

I a woke at 4 am a little better than when I went to bed. Too tired to ty=
pe
more. Have apt. with social security examiner today  at least they picked=
 a
good day for me to be a basket case at the time of my examination.
I am also having cramps in parts of body that did not previousy cramp suc=
h as
neck and right leg and hand.  Today I am 57 and my wife has baked my favo=
rite
cake. Chocolate with 7 minute vinalia frosting

------------------------------

Date:    Thu, 4 Dec 1997 07:12:22 -0400
From:    janet paterson <[log in to unmask]>
Subject: dear

when we see how funny we are
we see how dear we are

        anne wilson schaef



janet [log in to unmask]

------------------------------

Date:    Thu, 4 Dec 1997 07:33:48 -0500
From:    Perry Sennewald <[log in to unmask]>
Subject: Re: BERNIE BARBER'S WP FILE CONVERTED TO TXT <fwd>

My compliments to the really cogent comments by Dr. Charles Meyer on
"unification" of PD organizations.  I recognize that the author may have
been Dr. Bernie Barber; forgive me, as I may have not been able to sort
this out correctly given the many messages flying around on the subject
along with file conversion problems.  My comments assume I am correct in
naming Dr. M as the author.  Hopefully, some one will correct me if I am
wrong.

I am new to the list and have been off due to travel up until a week ago.
When I returned, I found all the many differing views on a subject that
came up while I was off the list.  What was clear, however, was a certain
lack of clarity of purpose and an element of reality.  Dr. Meyer has
provided that and more in my view - especially the reality check.

Allow me to provide just a bit of support for the thesis of an independen=
t
"Parkinson Information Exchange" as articulated by Dr. Meyer.  I have had
just a brief exposure of about eight weeks[excluding my break of two week=
s
for travel]to the list.  As a result, I have learned more about PD and it=
s
many characteristics, and how to manage it than I have from reading
materials and surfing the net.  Please don't misunderstand; the latter tw=
o
are invaluable, but the PIE has allowed me as a new CG to begin to
integrate all the bits and pieces of data into a much better picture of P=
D
than otherwise would have been possible.  For this I am appreciative of t=
he
existence of this list and the CG list.  Kudos to all the folks that make
both possible.

I would offer only one minor critique of both lists:  At times, informati=
on
is distributed that sometimes seems not to be terribly relevant to PWP, P=
D,
and to CGs.  But then, as Dr. Meyer pointed out, that what democracy is a=
ll
about.   I believe it was Winston Churchill who once said in effect:
democracy is a terrible system, but it sure beats all the alternatives.

Again, my compliments to Dr. Meyer for his thoughts and here's to an even
more effective PIE in the future.

                Perry Sennewald 69 new CG for Terry 70/0.25 [psennewald@m=
onmouth.com

------------------------------

Date:    Thu, 4 Dec 1997 07:49:27 -0500
From:    "Barbara A. Jarjoura" <[log in to unmask]>
Subject: Re: Requip Diary Days 8 thru 12 by Dale Severance

Good morning Dale,

You did indeed pick a good time to go to the SS.

I just wanted to let you know that Fuad went through a similar reaction, =
but
finally at week 6 with no Sinemet he is starting to improve.  He is on 12=
 mg a
day 4 mg x 3 and is showing signs of overmedication.

The positive side is that his mind is clearer and he is able to do the ph=
ysical
therapy better.  To help with the aches he has been taking Nuprin.

Try to hang in there if you can.

Barb
CG for Fuad (60) dx 4+  PD 25+

digest Dale Severance wrote:

> 12/3/97  Day 8th thru 12th on requip
>
> I have been so bad I could not keep up the diary. I have been frozen to=
 the
> point I could barely initiate any action.
> During this period I titrated up to 1 mg 3x a day and today starts 1mg =
3x a
> day
> I've slept most of the time the last 3-4 days letting the tiredness and
> fatigue take its course. My  freezing has effected my upper body more t=
han
> lower part but both effected.
>
> I a woke at 4 am a little better than when I went to bed. Too tired to =
type
> more. Have apt. with social security examiner today  at least they pick=
ed a
> good day for me to be a basket case at the time of my examination.
> I am also having cramps in parts of body that did not previousy cramp s=
uch as
> neck and right leg and hand.  Today I am 57 and my wife has baked my fa=
vorite
> cake. Chocolate with 7 minute vinalia frosting

------------------------------

Date:    Thu, 4 Dec 1997 07:57:51 -0500
From:    "Barbara A. Jarjoura" <[log in to unmask]>
Subject: Re: Requip Diary Days 8 thru 12 by Dale Severance

HAPPY BIRTHDAY DALE!!!!!

digest Dale Severance wrote:

> 12/3/97  Day 8th thru 12th on requip
>
> I have been so bad I could not keep up the diary. I have been frozen to=
 the
> point I could barely initiate any action.
> During this period I titrated up to 1 mg 3x a day and today starts 1mg =
3x a
> day
> I've slept most of the time the last 3-4 days letting the tiredness and
> fatigue take its course. My  freezing has effected my upper body more t=
han
> lower part but both effected.
>
> I a woke at 4 am a little better than when I went to bed. Too tired to =
type
> more. Have apt. with social security examiner today  at least they pick=
ed a
> good day for me to be a basket case at the time of my examination.
> I am also having cramps in parts of body that did not previousy cramp s=
uch as
> neck and right leg and hand.  Today I am 57 and my wife has baked my fa=
vorite
> cake. Chocolate with 7 minute vinalia frosting

------------------------------

Date:    Thu, 4 Dec 1997 06:31:58 -0700
From:    "Kathrynne Holden, MS,RD" <[log in to unmask]>
Subject: Re: I've learned...

This is a multi-part message in MIME format.
--------------FB466497E0491020A01616A9
Content-Type: text/plain; charset=3Dus-ascii
Content-Transfer-Encoding: 7bit

Art -- thanks! this one made my day:


>  I've learned that you can't hide a piece of broccoli in a glass of
>  milk.  Age 6



--------------FB466497E0491020A01616A9
Content-Type: text/x-vcard; charset=3Dus-ascii; name=3D"vcard.vcf"
Content-Transfer-Encoding: 7bit
Content-Description: Card for Kathrynne Holden, MS, RD
Content-Disposition: attachment; filename=3D"vcard.vcf"

begin:          vcard
fn:             Kathrynne Holden, MS, RD
n:              Holden, MS, RD;Kathrynne
org:            Five Star Living, Inc.
adr:            ;;;;;;USA
email;internet: [log in to unmask]
title:          Registered Dietitian
tel;work:       970-493-6532
tel;fax:        970-493-6538
note:           http://www.fortnet.org/~fivstar
x-mozilla-cpt:  ;0
x-mozilla-html: TRUE
version:        2.1
end:            vcard


--------------FB466497E0491020A01616A9--

------------------------------

Date:    Thu, 4 Dec 1997 22:43:10 +0700
From:    David Havard <[log in to unmask]>
Subject: Re: Another Survey? Brian Collins et al

To Brian Collins and the five other respondents (thank you)

I guess that I was a bit naive to think that a survey would be easy to
organize.  There have been only eight replies to the question and the
two negative (not that yours was directly negative Brian) replies cast
doubt on what I see as an essential base - a statistically valid
response (from the membership).
Given the obvious (the likelihood of a small and slow response), there
will not be enough time to organize, collate and analyze the data before
I lose the Internet connection.  At this time, therefore, I regretfully
will not attempt to start a survey now.
In the few days since the original posting there have been several
questions from people concerning new agonists and other drugs.  I am
still of the opinion that the concept of the survey is valid, but I
believe the amount of time I have available is insufficient to carry out
the survey.  If people will support the survey I will try and organize
something in March and/or April when I  am back on the Internet.
Brian, I agree with the three numbered suggestions set out below.  If we
can get the required interest, I will be prepared to be proactive and
chase answers to get as near a valid sample as possible.
Thanks very much for your support and interest.

David



Brian Collins wrote:
>
> it is the> problem of the small number of responses that typically resu=
lt from such
> a survey. It seems reasonable to expect a response in the realm of 100 =
to
> 200 from the 1500 members of the list, and armed with that sort of data
> we might begin to get some  useful information. I would suggest a few
> guidelines as follows:
>
> 1. Make the question(s) simple, unambiguous, and relevant
>
> 2 Phrase the question(s) in such a way that the answer(s) can be short
> and direct.
>
> 3 Get the support of some of the more regular contributors to the list:
> If they can stir their 'fan clubs' into action who knows - we might beg=
in
> to get somewhere.  I suspect that if we could get one large-scale respo=
nse,
> and show the potential of 'people-power' it may begin to snowball into =
a
> really useful service.  - How many neurologists have access to 1500
> potential responders ?
>
> Re: the second opinion request, I am prepared to do this (Of course, I =
may
> not agree with your findings, but I assume that you are prepared for th=
is).
>
> Regards,
> --
> Brian Collins  <[log in to unmask]>

------------------------------

Date:    Thu, 4 Dec 1997 10:32:28 -0500
From:    Judith Richards <[log in to unmask]>
Subject: FW: Elizabeth Butler

Sorry for posting private mail to the List, but I've had my post to
Elizabeth returned twice...

>Hi Liz,
>
>Here's the info you wanted. There is a nice "thank you" note from Johnny
Cash on his web site to all his fans.

>http://www.johnnycash.com
>
>CASH, An Autobiography
>
>"This book will be my whole story =97 what I feel, what I love, what's
happened, as I remember it. It's time to cut through some of the rumors.
>If my life has anything to say, I'll say it here."
>
>Johnny Cash celebrates sixty-five years and his remarkably varied career=
 in
a riveting autobiography =97 telling it straight =97 in his own words. CA=
SH: The
Autobiography (a HarperSanFrancisco Hardcover/October 15, 1997/$25.00), i=
s
co-authored with Patrick Carr, contributing editor of Country Music magaz=
ine.
>
>Here, Cash tells the whole story: from his roots on an Arkansas cotton f=
arm
to his first public performance during an Air Force stint in Germany; the
Sun Records era of the '50s, when he worked with Elvis and Carl Perkins, =
to
the amphetamine-laced '60s; his marriage to June Carter; the "supertar"
years when he had his own TV show; his treatment for addiction and spirit=
ual
>revival and exciting comeback. He relates the traumatic experiences of h=
is
life, such as the death of his older brother and the violent robbery at h=
is
home in Jamaica. Cash also reflects on the family and spirituality that i=
s
central to his life and recalls associations with Jerry Lee lewis, Elvis,
Bob Dylan and many others, including presidents from Nixon to Clinton.
>
>"I love the road, I love being a gypsy. In some important ways I live fo=
r
it, and in other ways it keeps me alive," says Cash. "If I couldn't keep
traveling the world and singing my songs to real live people who want to
hear them, I think I might just sit myslf down in front of a TV and start=
 to
die ... For ultimately, even with its little hardships and major challeng=
es,
that's what the road really means to me. It's adventure, companionship,
creativity, freedom. It's the voice of a very old, beloved friend, perhap=
s a
boy back in Arkansas or a young man in Memphis, still fresh and clear
despite years, calling: 'Come on, J.R., let's go play!' "
>
>Full of never-before-published photos, his epic story offers the unique
perspective of a legend reflecting on his own life and a fascinating blen=
d
of passion, honesty, humor, insight, and inspiring faith. With enormous
appeal for fans both old and new, CASH captures the voice of this America=
n icon.
>
>Order your copy today by e-mailing us with your credit card information =
or
by calling 1-800-996-3977!
>
>About the authors: Born in Kingsland, Arkansas, Johnny Cash is the only
musician to be inducted into the Songwriter's Hall of Fame, the Country
Music Hall of Fame, and the Rock and Roll Hall, and is one of only a hand=
ful
of entertainers to sell more than 50 million records. Cash lives with his
wife and longtime singing parterner June Carter Cash in Hendersonville,
Tennessee. Patrick Carr has covered the rock and country music scenes for
Rolling Stone, the New York Times, Village Voice and Playboy. The editor =
of
The Illustrated History of Country Music, and coauthor, with Angela Bowie=
,
of Backstage Passes: Life on the Wild Side with David Bowie, he lives in
Tampla, FL.
>
>Copyright 1997 Odyssey Publications. Updated 10/20/97
>
>At 02:35  04/12/97 +1000, Elizabeth Butler wrote:
>>Hi Judith
>>Saw your list post re Johnny Cash and wondered whether you could help m=
e
>>with a question from one of our support group members.  I did try to po=
st
>>to the list but seem to have messed that up somehow.
>>Do you know if there has been an autobiography published and if so coul=
d
>>you send me details please.
>>Cheers
>>Elizabeth Butler
>>aka ^yak^ on #parkinsons
>>Gold Coast Australia

------------------------------

Date:    Thu, 4 Dec 1997 12:26:08 -0500
From:    Richard Henderson <[log in to unmask]>
Subject: Re: PMID: 9371905: Olfactory dysfunction in familial PD 27/0 USA=
 -Reply

The efficiency of the nasal plasters(across the bridge of the nose) is
certainly guarenteed as many sportsmen/women wear them to increase
the flow of air into the lungs; they also come in a flesh colour. However=
,
wearing one in public may make you look as if youve accidently cut your
nose while shaving!

------------------------------

Date:    Thu, 4 Dec 1997 10:37:53 -0800
From:    "J. R. Bruman" <[log in to unmask]>
Subject: CSRINDX DEC 97 Part 2 of 2

"     "           J Neur N'surg Psych 1996;61:634-637   Aug 96
     "     "           Mov Disord          1997;12:103-106   Feb 97
     "     "           Ann Neur            1997;42:245-248   Sep 97
     "     "           Neur                1997;49:438-444   Oct 97
     "     "           Ann Neur            1997;42:349-355   Oct 97
     "     "           Clin Neuropharm     1997;20:394-401   Dec 97
     "     "           Clin Neuropharm     1997;20:409-418   Dec 97
     "   ethylester    Ann Neur            1996;39:400-404   Apr 96
     "   metabolism    Ann Neur            1997;42:300-304   Oct 97
     "   strategy      Ann Neur            1995;38:389-395   Oct 95
     "       "         J Neur N'surg Psych 1995;59:555       Dec 95
     "       "         Neur                1996;47:Supp 3    Feb 97
     "       "         Neur                1997;49:711-713   Oct 97
     "   toxicity      Mov Disord          1997;12:634-638   Nov 97
Lewy body disease      J Neur N'surg Psych 1996;60:531-538   Jun 96
     "                 Neur                1996;47:462-466   Sep 96
     "                 Neur                1997;48:376-380   Mar 97
     "                 Science News        18 Oct 1997:255   Nov 97
Liquid Sinemet         Neur                1996;47:1493-1495 Feb 97
Locus coeruleus        Brain               1995;118:131-143  Jun 95
Machado-Joseph         Ann Neur            1995;38:684-687   Nov 95
Macrophage             Science News        21 Sep 96:180     Oct 96
Magnetic stimulation   Brain               1996;119:71-77    May 96
     "                 Brain               1996;119:815-822  Sep 96
     "                 Ann Neur            1996;40:344-355   Oct 96
     "                 Brain              1997;120:1587-1602 Nov 97
MAO inhibition, effect J Neurosci          1997;17:2267-2272 May 97
MAO-B                  Neur                1996;46:1262-1269 Jun 96
     "                 Ann Neur            1996;40:99-107    Aug 96
Markers, neurochemical Neur                1996;47:718-726   Oct 96
     "        "        Mov Disord          1997;12:167-174   May 97
     "        "        Ann Neur            1997;41;530-539   May 97
Melatonin              BMJ                 18 May 96:1242-43 Jun 96
     "  ,  antioxidant J Neurosci          1997;17:1683-1690 Apr 97
Memory, Hippocampus    Science News        7 Sep 1996:150    Oct 96
Memory and PD          Science             6 Sep 96:1263-64  Oct 96
     "                 Science             6 Sep 96:1399-02  Oct 96
     "                 J Neur N'surg Psych 1997;62:410-413   Jun 97
Menstrual effects      Neur                1995;45:1028      Jul 95
     "                 Mov Disord          1993;8:240-241    Nov 95
Metaclopramide (Reglan)JAMA                1995;274:1780-82  Jan 96
Metals, exposure to    Neur                1997;48:650-658   Apr 97
Methylsalsolinol       Ann Neur            1996;40:119-122   Aug 96
Metronome              Lancet              11 May 1996:1337  Jun 96
Migraine, DA and       Clin Neuropharm     1997;20:36-41     May 97
Mimics of PD           Arch Neur           1995;58:294-298   Oct 95
     "                 Brain               1995;118:951-958  Oct 95
     "                 BMJ                 16 Mar 1996:724   Apr 96
Mitochondria           Science News        5 Aug 1995;84     Sep 95
     "                 Neur                1995;45:2097-2099 Feb 96
     "                 Mov Disord          1997;12:3-16      Feb 97
     "                 Mov Disord          1997;12:639-645   Nov 97
Mortality              J Neur N'surg Psych 1995;58:293-299   Apr 95
     "                 Arch Neur           1997;54:260-264   Apr 97
Motor cognition        Brain               1997;120:1339-53  Oct 97
  "      "             Brain               1997;120:1355-75  Oct 97
  "   fluctuations     J Neur N'surg Psych 1996;61:634-637   Aug 96
  "   skill learning   Brain               1997;120:1325-37  Oct 97
Movement, head and eye Ann Neur            1996;39:749-760   Jul 96
  "     , coordinated  Brain               1997;120:91-102   Apr 97
  "     ,     "        Brain               1997;120:593-604  Jun 97
  "     ,     "        Brain               1997;120:963-976  Aug 97
  "     ,     "        Mov Disord          1997;12:665-676   Nov 97
  "     ,     "        Mov Disord          1997;12:646-654   Nov 97
  "     ,     "        Brain               1997;120:2093-111 Dec 97
  "     , diagnostic   Arch Neur           1997;54:450-454   May 97
  "     , guidance     Brain               1997;120:977-990  Aug 97
MPTP                   Ann Neur            1994;36:765-770   Dec 94
  "                    J Neurosci          1996;16:7776-7782 Jan 97
  "                    Neur                1996;47:Supp 3    Feb 97
Multiple System AtrophyAnn Neur            1995;37:204-210   Mar 95
     "                 J Neur N'surg Psych 1995;59:144-151   Sep 95
     "                 Clin Neuropharm     1997;20:239-244   Sep 97
Muscle, sound from     Lancet              22 Feb 97;533-535 Apr 97
Nerve Growth Factor    J Neurosurg         1996;84:685-689   Apr 96
     "                 J Neurosci          1996;16:5437-5442 Nov 96
     "                 J Neurosci          1996;16:6433-6442 Nov 96
     "                 J Neurosurg         1997;86:511-518   Jul 97
     "  and diabetes   Lancet              19 Oct 96:1044-45 Nov 96
Neuroleptics (risk)    J Neur N'surg Psych 1996;60:213-216   Mar 96
Neuropeptides          Brain               1996;119:823-830  Sep 96
Neurosciences Inst.    Science             27 Oct 1995:572   Dec 95
Neurotrophic factors   Ann Neur            1996;40:346       Oct 96
     "    problems     Nat Med             1997;3:497        Jul 97
     "       (BDNF)    J Neurosci          1997;17:2295-2313 May 97
Neurotrophic (GDNF)    WSJ                 21 Mar 1996:      Apr 96
     "                 N Neurosci          1996;16:8132-8139 Jan 97
NMDA antagonist        J Neurosci          1996;16:4231-39   Nov 96
     "                 J Neurosci          1997;17:2921-2927 May 97
Nurr-1                 Science             11 Apr 97:248-50  May 97
     "  , editorial    Science             11 Apr 97:202     May 97
Nutrients and PD       Neur                1996;47:644-650   Oct 96
Olfaction and PD       J Neur N'surg Psych 1997;62:436-446   Jul 97
Ondansetron (Zofran)   Neur                1995;45:1305-1308 Oct 95
     "                 Neur                1996;47:1608-1609 Feb 97
     "  , for tremor   J Neur N'Surg Psych 1997;62:282-284   Apr 97
On-off effect          J Neur N'surg Psych 1995;59:555       Dec 95
     "                 J Neur N'surg Psych 1996;61:634-637   Aug 96
Onset, early vs late   Mov Disord          1997;12:277-284   Aug 97
Oxidative stress       Neur                1995;45S3:55      May 95
     "                 J Neur N'surg Psych 1995;59:90-91     Aug 95
     "                 Ann Neur            1996;39:378-381   Apr 96
Pallidopyramidal       Ann Neur            1995;38:954-956   Feb 96
Pallidotomy, boom in   WSJ                 22 Feb 95:1       Mar 95
     "      , benefits Neur                1995;45:753-761   Jun 96
     "      ,    "     Lancet              25 May 96;1490    Jul 96
     "      ,    "     Ann Neur            1996;39:826       Jul 96
     "      ,    "     J Neur N'surg Psych 1997;62:125-132   Apr 97
     "      ,    "     Lancet              15 Mar 1997:777   Apr 97
     "      ,    "     Neur                1997;48:1273-1277 Jun 97
     "      ,    "     Ann Neur            1997;41:834       Jul 97
     "      ,    "     Arch Neur           1997;54:1026-1029 Oct 97
     "      ,    "     J Neurosurg         1997;87:358-367   Oct 97
     "      ,    "     Neur                1997;49:1072-1077 Nov 97
     "     , cognition Arch Neur           1997;54:947-950   Sep 97
     "       and DBS   Nat Med             1997;3:671-674    Jul 97
     "           "     Nat Med             1997;3:602-603    Jul 97
     "           "     Neur                1997;49;1078-1083 Nov 97
     "      , effects  J Neur N'surg Psych 1997;63:150-162   Oct 97
     "   , gamma knife Ann Neur            1996;39:535-538   Jun 96
     "      , history  Ann Neur            1996;40:341-343   Oct 96
     "      , low-cost Brain               1997;120:729-737  Jul 97
     "      , PET scan Ann Neur            1995;37:776-783   Jul 95
     "      ,    "     Ann Neur            1996;39:450-459   Jun 96
     "      ,    "     Brain               1997;120:1301-13  Oct
97          "      ,    "     Brain               1997;120:1315-24  Oct
97
     "      , success  Ann Neur            1996;40:355-366   Oct 96
     "      ,    "     Neur                1997;1083-1090    Nov 97
     "      ,    "     Mov Disord          1997;12:752-755   Nov 97
     "     , technique J Neurosurg         1996;84:194-202   Jul 96
     "     ,     "     J Neurosurg         1996;85:1005-1012 Jan 97
     "     ,     "     J Neurosurg         1997:87:52-59     Aug 97
Paroxetine (Paxil)     Neur                1994;44:2406      Jan 95
Pathways, neural       Neur                1995;45S3:S28-S34 May 95
     "                 Neur                1996;1032-1036    Nov 96
Perception, auditory   Mov Disord          1997;12:655-664   Nov 97
     "    , visual     Brain               1996;119:79-87    May 96
Pergolide (Permax)     Neur                1995;45S3:S5      May 95
     "                 Neur                1995;45S3:S13-S21 May 95
     "                 Neur                1995;45S3:S22-S27 May 95
     "                 Mov Disord          1997;12:402-407   Aug 97
Personality and PD     Lancet              15 Feb 97:478     Mar 97
PET diagnosis          Ann Neur            1994;36:759-764   Dec 94
     "                 Ann Neur            1994;2:176-182    Dec 94
     "                 J Neur N'surg Psych 1995;59:597-600   Jan 96
     "                 Neur                1995;45:1995-2004 Feb 96
     "                 Ann Neur            1996;39:450-459   Jun 96
     "                 Neur                1996;46:1430-1436 Jun 96
     "                 Neur                1996;46:1200-1205 Jun 96
     "                 Ann Neur            1996;39:650-658   Jun 96
     "                 Brain               1996;119:585-591  Jul 96
     "                 Neur                1996;47:462-466   Sep 96
     "                 Ann Neur            1996;40:873-884   Mar 97
     "                 Ann Neur            1997;41:58-64     Mar 97
  "  scans, questioned Science             11 Apr 97:196-198 May 97
Pituitary, effects on  Clin Neuropharm     1996;19(1):72-80  Dec 97
Porphyria and PD drugs J Neur N'surg Psych 1997;62:562       Jul 97
Post-encephalitis PD   Ann Neur            1997;42:356-359   Oct 97
Pramipexole            PDF Newsletter      Spr 1996:1        Apr 96
     "                 JAMA                9 Jul 87:125-130  Aug 97
     "                 Neur                1997;49:162-168   Aug 97
     "                 Neur                1997;49:724-728   Oct 97
     "                 Neur                1997;49:1060-1065 Nov 97
Prevalence             J Neur N'surg Psych 1997;62:10-15     Mar 97
Prions                 Science News        13 Apr 1996;228   May 96
Progenitor cells       Eng. & Sci          Sept 95:26        Nov 95
Progression (case hist)NEJM                1996;334:116-118  Feb 96
     "                 JAMA                6 Mar 1996:716    Apr 96
     "                 JAMA                9 Oct 1196;1171   Nov 96
     "  , in putamen   Brain               1996;119:2097-103 Mar 97
Progressive Supranuc.  J Neur N'surg Psych 1996;60:589       Jun 96
     "                 J Neur N'surg Psych 1996;61:615-620   Aug 96
     "                 Neur                1996;47:1-9       Sep 96
     "                 Neur                1996;47:148-154   Sep 96
     "                 Brain               1997;120:65-74    Apr 97
     "                 Arch Neur           1997;54:1104-1108 Oct 97
Propranolol (Inderal)  Neur                1996;46:1548-1551 Jul 96
Propath program        Arch Neur           1996;53:881-884   Oct 96
Proton Magnetic Res.   J Neur N'Surg Psych 1997;62:239-242   Apr 97
Prozac (fluoxetine)    Neur                1995;45:1855-1858 Nov 95
Psychogenic PD         Arch Neur           1995;52:802-810   Sep 95
Quality of life        J Neur N'surg Psych 1996;61:71-74     Aug 96
Raclopride, in PET     Mov Disord          1997;12:33-38     Feb 97
Rapid-onset            Neur                1997;49:1066-1069 May 97
Rating scale, clinical Clin Neuropharm     1997;20:183-184   Sep 97
     "           "     Clin Neuropharm     1997;20:322-327   Sep 97
Reaction time          J Neur N'surg Psych 1995;59:499-506   Dec 95
     "                 Brain               1996;119:1689-1704Jan 97
Reflex blink, and PD   J Neurosci          1996;16:7308-7330 Dec 96
Regeneration, brain    Lancet              16 Mar 1996:751   Apr 96
     "                 Science News        21 Sep 1996:180   Oct 96
     "                 Science             28 Feb 97;1318-19 Apr 97
     "  , spinal cord  Lancet              21 Sep 1996:814   Oct 96
Registry (surveys)     Neur                1995;45:1991-1995 Feb 96
     "                 NEJM                1996;334:71-76    Feb 96
     "                 Neur                1995;45:2143-2146 Feb 96
     "                 Arch Neur           1996;53:66-71     Feb 96
Research priorities    JAMA                25 Oct 95:1257-8  Nov 95
Response time, levodopaNeur                1996;46:1055-1058 Jun 96
     "                 Neur                1996;46:1059-1062 Jun 96
Restless leg syndrome  JAMA                17 Jan 1996:      Feb 96
     "                 Neur                1996;47:1435-1441 Feb 97
     "                 Clin Neuropharm     1997;20:148-151   May 97
     "                 Mov Disord          1997;12:402-407   Aug 97
Rigidity               Mov Disord          1997;12:24-32     Feb 97
Risperidone            Mov Disord          1997;12:119-121   Feb 97
     "                 Mov Disord          1997;12:610-612   Sep 97
Ropinirole             Neur                1997;49:393-399   Oct 97
Salsolinol             Ann Neur            1996;40:119-122   Aug 96
Selegiline, amphetamineLancet              1995;346:64       Oct 95
     "      , and AD   NEJM                14 Apr 97:1216-22 May 97
     "      , benefits Ann Neur            1995;37:95-98     Feb 95
     "      ,     "    Mov Disord          1997;12:175-182   May 97
     "      ,     "    Ann Neur            1997;41:833-834   Jul 97
     "      ,  DATATOP Arch Neur           1995;52:237-245   Apr 95
     "      ,     "    Arch Neur           1995;52:564-570   Nov 95
     "      ,     "    Ann Neur            1996;39:37-45     Mar 96
     "      ,     "    Ann Neur            1996;39:29-36     Mar 96
     "      ,  dosage  Mov Disord          1997;12:293-296   Aug 97
     "   , in favor of PDF Newsletter      Spr 1996:2        Apr 96
     "      , PET scan Ann Neur            1994;36:759-764   Dec 94
     "   , pro and con BMJ                 16 Mar 96:702-705 Apr 96
     "   ,   "  "   "  Ann Neur            1996;40:266-269   Sep 96
     "   ,   "  "   "  Ann Neur            1997;41:282-283   Mar 97
     " , protection by Ann Neur            1995;38:771-777   Jan 96
     " ,        "      J Neurochem         1997;68:33-39     Aug 97
     " ,        "      J Neurochem         1997;68:434-436   Aug 97
     "      , risks of BMJ                 16 Dec 95:1602-7  Jan 96
     "      ,   "      Ann Neur            1996;40:841-845   Mar 97
     "      ,   "      Neur                1997;48:662-667   Apr 97
     "      ,   "      Clin Neuropharm     1997;20:276-278   Sep 97
     "      ,   "      J Neur N'surg Psych 1997;63:228-234   Oct 97
     ", special review Neur                1996;47:Supp 3    Feb 97
Serotonin agonist      Neur                1997;49:1168-1170 Nov 97
     "       "         Mov Disord          1997;12:756-759   Nov 97
     "    antagonist   Clin Neuropharm     1997;20:300-310   Sep 97
     "    syndrome     Neur                1997;48:1070-1077 Mar 97
Sertoli cells          Nat Med             1997;3:1129-1132  Nov 97
Shy-Drager             Ann Neur            1995;37:204-210   Mar 95
Sinemet, dissolved     Mov Disord          1997;12:608-610   Sep 97
Sinemet CR             J Neur N'surg Psych 1995;58:ad        Jul 95
     "                 Lancet              11 Nov 1995;1290  Dec 05
     "                 Mov Disord          1997;12:677-681   Nov 97
Sjogren's syndrome     Mov Disord          1997;12:121-123   Feb 97
Sleep, violence in     Lancet              19 Apr 97;1150    Jun 97
  "  , benefit         Mov Disord          1997;12:506-508   Sep 97
Smell, loss of         J Neur N'surg Psych 1997;62:436-446   Jul 97
Smoking and PD         Neur                1995;45:1041      Sep 95
     "                 Neur                1995;58:294-298   Oct 95
     "                 Time                11 Mar 1996:60    Apr 96
     "                 Lancet              24 Feb 1996:527   Apr 96
     "                 Ann Neur            1996;39:378-381   Apr 96
     "                 Neur                1996;46:1275-1284 Jun 96
SPECT, diagnosis by    Neur                1996;46:278-285   Apr 96
     "                 Neur                1996;46:231-237   Apr 96
     "                 Brain               1997;120:103-110  Apr 97
     "                 J Neur N'surg Psych 1997;62:133-140   Apr 97
Speech therapy         Neur                1996;47:1496-1504 Feb 97
Stem cells, cultured   Science News        19 Jul 97:36      Aug 97
     "    , review of  Science             4 Apr 1997:66-71  May 97
Stereotactic           J Neurosurg         1995;83:197-205   Aug 95
     "                 Science News        30 Mar 1996:204   Apr 96
Stimulation, chronic   Neur                1996;46:1150-1153 Jun 96
     "                 Arch Neur           1996;53:898-903   Oct 96
     "                 Neur                1997;49:1078-1083 Nov 97
Strategy, summary      Clin Neuropharm     1997;20:95-115    May 97
Strength, arm          Ann Neur            1996;39:79-88     Mar 96
     "                 Brain               1997;120:401-408  Jun 97
Striatonigral degener- Neur                1996;47:1032-1036 Nov 96
Stroke, help from      Mov Disord          1997;12:124-126   Feb 97
   "  , adverse effect J Neur N'surg Psych 1997;62:288-289   Apr 97
   "  ,    "           Neur                1997;49:707-710   Oct 97
   "  ,    "           Nat Med             1997;3:1129-1132  Nov 97
Surgery, summary       J Neur N'surg Psych 1997;62:2-8       Mar 97
Swallowing             Neur                1997;48:373-375   Mar 97
    "                  Mov Disord          1977;12:322-327   Aug 97
Sweats, control of     Ann Neur            1995;37:120-122   Mar 95
Symmetrel (Amantadine) Neur                1996;46:1551-1556 Jul 96
Tachyphemia            Mov Disord          1997;12:302-305   Aug 97
Tacrine, PD symptoms   J Neur N'surg Psych 1996;61:324-325   Oct 96
Tactile acuity         Neur                1997;49:168-177   Aug 97
Tardive dyskinesia     Mov Disord          1997;12:119-121   Feb 97
    "      " , and PVP Lancet              15 Mar 1997:777   Apr 97
Terguride              Clin Neuropharm     1996;19(1):72-80  Dec 97
Tetanus shot caused    J Neur N'surg Psych 1997;63:258       Oct 97
Thalamotomy            J Neur N'surg Psych 1996;60:564-571   Jun 96
     "                 Brain               1996;119:1717-27  Jan 97
     "                 Ann Neur            1997;41:108-111   Mar 97
Thalamus, and tremor   Neur                1996;46:75-79     Mar 96
     "                 Neur                1996;46:1150-1153 Jun 96
Therapy, tutorial      Western J Med       1994;161:303-308  Jul 96
     "                 Postgrad Med        1996;99:52-68     Jul 96
     "                 Sci Amer Medicine   Part 11, Chap XV  Dec 97
Time, judgement of     Science News        17 Feb 1996:101   Mar 96
     "                 Brain               1996;119:51-70    May 96
Tolcapone              Neur                1997;48:81-87     Feb 97
     "                 Lancet              6 Sep 1997:712    Oct 97
     "                 J Neur N'surg Psych 1997;63:421-428   Nov 97
     "                 Neur                1997;1066-1071    Nov 97
Tourette Syndrome      Mov Disord          1997:12:402-407   Aug 97
Toxins, Environmental  Ann Neur            1994;36:765-770   Dec 94
     "                 Neur                1995;45:435-439   Apr 95
     "                 Neur                1995'45:2112      Feb 96
     "                 Neur                1997;48:1583-1588 Jul 97
Tracking, visual       Brain               1995;118:485-493  Jul 95
Transcranial mag. stim J Neurosci          1997;17:3178-3184 May 97
     "                 Mov Disord          1997;12:315-321   Aug 97
Tremor, resting PD     Neur                1996;46:1359-1370 Jun 96
     ", cerebellar     J Neur N'surg Psych 1997;62:282-284   Apr 97
     ", surgery for    J Neurosurg         1997;86:642-647   May 97
Ubiquitin              Brain               1995;118:1447-49  Feb 96
Urinary dysfunction    J Neur N'surg Psych 1997;62:507-511   Jul 97
     "      "          Mov Disord          1997;12:509-513   Sep 97
Valproate              Neur                1996;47:626-635   Oct 96
Visual perception      Brain               1996;119:79-87    May 96
Vision abnormality     Neur                1995;45:1144-1148 Oct 95
Visuospatial attention Brain               1995;118:153-166  Jun 95
Weight loss            Neur                1997;48:88-91     Feb 97
Wine and dementia      BMJ                 5 Apr 97:997      May 97
Young onset            Neur                1996;47:225-230   Sep 96
   "    "              Mov Disord          1997;12:277-284   Aug 97
Zolpidem               Lancet              26 Apr 97:1222-23 Jun 97
    "                  Lancet              5 Jul 97:74       Aug 97

 J. R. Bruman   (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013

------------------------------

End of PARKINSN Digest - 3 Dec 1997 to 4 Dec 1997 - Special issue
*****************************************************************


--part0_881619373_boundary--